Novolog Pharm-Up 1966 Ltd Cash Flow Conversion Efficiency

Latest as of December 2025: -0.120x

Novolog Pharm-Up 1966 Ltd cash flow conversion efficiency. Based on the latest financial reports, Novolog Pharm-Up 1966 Ltd (NVLG) has a cash flow conversion efficiency ratio of -0.120x as of December 2025. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (ILA-44.21 Million ≈ $-118.53K USD) by net assets (ILA368.90 Million ≈ $989.02K USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations. Also see market cap of Novolog Pharm-Up 1966 Ltd for the company's overall valuation and market capitalisation.

Cash Flow Conversion Efficiency of Novolog Pharm-Up 1966 Ltd (2014–2025)

Cash flow conversion efficiency of Novolog Pharm-Up 1966 Ltd from 2014 to 2025. This chart illustrates how Novolog Pharm-Up 1966 Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Novolog Pharm-Up 1966 Ltd share price for real-time trading data and today's change.

Novolog Pharm-Up 1966 Ltd Cash Flow Conversion Ratio Explained

Novolog Pharm-Up 1966 Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Novolog Pharm-Up 1966 Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Novolog Pharm-Up 1966 Ltd ranked by their cash flow conversion efficiency. Review Novolog Pharm-Up 1966 Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Company	Cash Flow Conversion Efficiency
Sula Vineyards Limited NSE:SULA	0.007x
Bogazici Beton Sanayi ve Ticaret AS IS:BOBET	0.087x
Digimarc Corporation NASDAQ:DMRC	-0.027x
Chongkundang KO:001630	0.008x
Complete Solaria, Inc. Common Stock NASDAQ:CSLR	1.474x
SaraminHR Co.Ltd KQ:143240	-0.026x
La Française de l'Energie S.A. PA:FDE	0.040x
Champion Microelectronic Corp TW:3257	0.083x

Annual Cash Flow Conversion Efficiency for Novolog Pharm-Up 1966 Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Novolog Pharm-Up 1966 Ltd from 2014 to 2025. Also see Novolog Pharm-Up 1966 Ltd asset portfolio for a full breakdown of the balance sheet.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	ILA368.90 Million ≈ $989.02K	ILA-16.50 Million ≈ $-44.24K	-0.045x	-110.78%
2024-12-31	ILA382.14 Million ≈ $1.02 Million	ILA158.52 Million ≈ $424.98K	0.415x	-17.85%
2023-12-31	ILA396.12 Million ≈ $1.06 Million	ILA200.01 Million ≈ $536.23K	0.505x	+75.88%
2022-12-31	ILA462.05 Million ≈ $1.24 Million	ILA132.65 Million ≈ $355.62K	0.287x	+48.12%
2021-12-31	ILA430.23 Million ≈ $1.15 Million	ILA83.39 Million ≈ $223.56K	0.194x	-2.01%
2020-12-31	ILA295.67 Million ≈ $792.68K	ILA58.48 Million ≈ $156.80K	0.198x	-48.57%
2019-12-31	ILA263.78 Million ≈ $707.18K	ILA101.45 Million ≈ $271.99K	0.385x	+63.10%
2018-12-31	ILA101.61 Million ≈ $272.42K	ILA23.96 Million ≈ $64.24K	0.236x	-76.60%
2017-12-31	ILA85.71 Million ≈ $229.79K	ILA86.37 Million ≈ $231.56K	1.008x	+251.15%
2016-12-31	ILA70.68 Million ≈ $189.49K	ILA20.28 Million ≈ $54.38K	0.287x	-79.07%
2015-12-31	ILA102.34 Million ≈ $274.37K	ILA140.29 Million ≈ $376.12K	1.371x	-25.93%
2014-12-31	ILA86.77 Million ≈ $232.63K	ILA160.59 Million ≈ $430.55K	1.851x	--

About Novolog Pharm-Up 1966 Ltd

TA:NVLG Israel Medical Distribution

Market Cap

$114.78 Million

ILA42.81 Billion ILA

Market Cap Rank

#18475 Global

#233 in Israel

Share Price

ILA83.80

Change (1 day)

-0.59%

52-Week Range

ILA66.80 - ILA137.60

All Time High

ILA337.91